Pleural Effusion Following Cardiac Surgery: Prevalence, Risk Factors and Clinical Features
NCT ID: NCT00665015
Last Updated: 2008-04-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2892 participants
OBSERVATIONAL
2004-01-31
2006-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Information was collected on all consecutive patients who underwent CABG surgery and/or valve replacement between January 1, 2004 and December 31, 2005. Demographic information, anthropometric parameters, cardiac and renal function assessments, and comorbid conditions were retrieved from medical files. We also collected data on the type of procedure, whether it was elective or urgent, the number and origin of the grafts, the duration of surgery and of cardiopulmonary bypass and the postoperative complications, including pleural effusions. Clinical presentation and evolution of the effusions as well as pleural fluid characteristics were also studied.
Patients were considered to have a clinically significant pleural effusion when they met at least one of the following criteria: need for thoracentesis, a pleural drainage tube or a hospital readmission due to a pleural effusion that occurred within one year of surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Valve replacement
* Combined CABG and valve replacement
* between January 1st, 2004 and December 31st, 2005
Exclusion Criteria
* Pulmonary and/or aortic artery surgery
* Heart or lung transplant
* Pleural effusion present at the time of surgery
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laval University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Unité de Recherche en Pneumologie, Hôpital Laval
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Louis-Philippe Boulet, MD, FRCP(C)
Role: PRINCIPAL_INVESTIGATOR
Unité de Recherche en Pneumologie, Hôpital Laval
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Unité de Recherche en Pneumologie, Hôpital Laval
Québec, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Labidi M, Baillot R, Dionne B, Lacasse Y, Maltais F, Boulet LP. Pleural effusions following cardiac surgery: prevalence, risk factors, and clinical features. Chest. 2009 Dec;136(6):1604-1611. doi: 10.1378/chest.09-0689. Epub 2009 Jul 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PEFCS-summer 07
Identifier Type: -
Identifier Source: org_study_id